20:13 , Dec 14, 2018 |  BC Week In Review  |  Financial News

Moderna raises $604M in record IPO, loses $1.4B in trading debut

Moderna Inc. (NASDAQ:MRNA) tumbled out of the gate on Dec. 7, losing $4.40 (19%) to $18.60 in its trading debut for a loss of $1.4 billion in market cap as U.S. stocks across the board...
03:38 , Dec 8, 2018 |  BioCentury  |  Finance

Moderna’s land grab

A blockbuster IPO by Moderna Inc. (NASDAQ:MRNA) gives the company the opportunity to make the case for mRNA. With more money, and a broader and more advanced pipeline than other players in the mRNA space,...
02:09 , Dec 7, 2018 |  BC Extra  |  Financial News

Moderna sets IPO record with upsized $604M offering

Brushing aside market volatility that has led several biotechs to miss their desired valuations in recent weeks, Moderna Inc. (NASDAQ:MRNA) raised $604.3 million in an upsized IPO late Thursday through the sale of 26.3 million...
18:28 , Nov 30, 2018 |  BC Week In Review  |  Financial News

Moderna proposes terms for record IPO

Moderna Inc. (Cambridge, Mass.) proposed terms for an IPO in which it would raise about $500 million. If the mRNA company succeeds, the deal would be the largest ever on NASDAQ for a precommercial biotech....
20:03 , Nov 28, 2018 |  BC Extra  |  Financial News

Moderna proposes terms for record IPO

Moderna Inc. (Cambridge, Mass.) proposed terms for an IPO in which it would raise about $500 million. If the mRNA company succeeds, the deal would be the largest ever on NASDAQ for a precommercial biotech....
15:59 , Nov 16, 2018 |  BC Week In Review  |  Financial News

At $500M, Moderna files to raise record IPO

mRNA company Moderna Therapeutics Inc. (Cambridge, Mass.) filed on Nov. 9 to raise $500 million in an IPO on NASDAQ, which would mark the largest IPO on the exchange for a development stage biotech. Flagship...
01:39 , Nov 10, 2018 |  BC Extra  |  Financial News

At $500M, Moderna files to raise record IPO

mRNA company Moderna Therapeutics Inc. (Cambridge, Mass.) filed to raise $500 million in an IPO on NASDAQ, which would mark the largest IPO on the exchange for a development stage biotech. Flagship Pioneering launched Moderna...
16:51 , Apr 2, 2018 |  BioCentury  |  Finance

Maintaining Moderna

A rumored dual listing on the Hong Kong stock exchange and NASDAQ could enable Moderna Therapeutics Inc. to maintain its ballooning valuation as it enters the public market. The mRNA play has raised $1.6 billion...
20:13 , Feb 9, 2018 |  BC Week In Review  |  Financial News

mRNA company Moderna raises $500M series G

Moderna Therapeutics Inc. (Cambridge, Mass.) raised $500 million in an untranched series G round on Feb. 1. New investors included an Abu Dhabi Investment Authority subsidiary, BB Biotech AG (SIX:BION; Xetra:BBZA), Julius Baer, EDBI and...
22:07 , Feb 2, 2018 |  BioCentury  |  Finance

Private ambition

BB Biotech AG (SIX:BION; Xetra:BBZA) made a rare private investment in Moderna Therapeutics Inc.’s $500 million series G round and wants to see clinical proof-of-concept data from at least one rare liver disease asset before...